日本語View as Markdown

Treatment with Hydrogen-Rich Saline Delays Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis.

筋萎縮性側索硬化症マウスモデルにおける水素富化生理食塩水投与による疾患進行抑制効果

animal study injection / infusion positive

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disorder in which oxidative and nitrosative stress are implicated in pathogenesis. This animal study examined the effects of intraperitoneally administered hydrogen-rich saline (HRS) in SOD1 G93A transgenic mice. HRS-treated animals showed delayed symptom onset and extended survival compared with controls. Motor neuron loss was reduced, and microglial as well as glial activation was suppressed. Mitochondrial apoptogenic factor release and downstream caspase-3 activation were inhibited by HRS. Markers of oxidative damage—including protein carbonyl, 3-nitrotyrosine, reactive oxygen species, peroxynitrite, and malondialdehyde—were all decreased. Mitochondrial function was preserved, evidenced by restored Complex I and IV activities, reduced mitochondrial ROS, and enhanced ATP synthesis. These findings suggest that molecular hydrogen exerts neuroprotective effects in ALS, likely through attenuation of oxidative/nitrosative stress and maintenance of mitochondrial integrity.

Mechanism

Molecular hydrogen scavenges ROS and peroxynitrite, restores mitochondrial Complex I and IV activities, suppresses release of apoptogenic factors, and inhibits caspase-3 activation, thereby protecting motor neurons from oxidative and nitrosative damage.

Bibliographic

Authors
Zhang YJ, Li H, Yang C, Fan DF, Guo DZ, Hu H, et al.
Journal
Neurochem Res
Year
2016
PMID
26537817
DOI
10.1007/s11064-015-1750-7

Tags

Mechanism:アポトーシス抑制 ヒドロキシルラジカル消去 炎症抑制 ミトコンドリア 酸化ストレス ペルオキシナイトライト消去 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Cite as: H2 Papers — PMID 26537817. https://h2-papers.org/en/papers/26537817
Source: PubMed PMID 26537817